Mutation of a conserved Asp (D98) in the rat serotonin (5HT) transporter (rSERT) to Glu (D98E) led to decreased 5HT transport capacity, diminished coupling to extracellular Na ϩ and Cl Ϫ , and a selective loss of antagonist potencies (cocaine, imipramine, and citalopram but not paroxetine or mazindol) with no change in 5HT K m value. D98E, which extends the acidic side chain by one carbon, affected the rank-order potency of substrate analogs for inhibition of 5HT transport, selectively increasing the potency of two analogs with shorter alkylamine side chains, gramine, and dihydroxybenzylamine. D98E also increased the efficacy of gramine relative to 5HT for inducing substrate-activated currents in Xenopus laevis oocytes, but these currents were noticeably dependent on extracellular medium acidification. I-V profiles for substrateindependent and -dependent currents indicated that the mutation selectively impacts ion permeation coupled to 5HT occupancy. The ability of the D98E mutant to modulate selective aspects of substrate recognition, to perturb ion dependence as well as modify substrate-induced currents, suggests that transmembrane domain I plays a critical role in defining the permeation pathway of biogenic amine transporters.
The Na ϩ -and C l Ϫ -dependent neurotransmitter transporters play a major role in the dynamic regulation of extracellular neurotransmitter concentrations. Not including species variants, this family of transporters is composed of more than 15 distinct members, including carriers for amino acid neurotransmitters as well as the monoamines serotonin (5HT), norepinephrine (NE), epinephrine, and dopamine (DA) (Nelson, 1998) . The 5HT transporter (SERT, 5HTT) is of particular clinical interest because it is a target for many antidepressants such as the tricyclic imipramine and the 5HT-selective reuptake inhibitors (SSRIs), including fluoxetine and paroxetine (Barker and Blakely, 1995; Tatsumi et al., 1997) as well as abused psychostimulants, including cocaine and the amphetamines (Rudnick and Wall, 1992; White, 1998) . Initial structural inferences suggest that the biogenic amine transporters exhibit cytoplasmic N H2 and C OOH tails, 12 putative transmembrane domains (TMDs), and a large extracellular loop between TMDs III and IV containing multiple sites for N-glycosylation (Nelson, 1998) . Although there has been some controversy regarding this model (Bennett and Kanner, 1997; Clark, 1997) , recent studies using the substituted cysteine accessibility method (SCAM) (Akabas et al., 1992; Stauffer and Karlin, 1994) have examined and supported the 12 TMD topology (Chen et al., 1998) . Despite a knowledge of the primary structure of SERTs and related transporters, little data are available that define how these domains interact with substrates and antagonists.
5HT transport studies of mammalian SERTs have provided mechanistic data for the kinetics governing the translocation of organic and ionic substrates through the membrane. 5HT influx is a co-transport process coupled to the inward movement of Na ϩ and Cl Ϫ with a predicted stoichiometry of 1 5HT/1 Na ϩ /1 Cl Ϫ for influx along with the countertransport of 1 K ϩ , thus predicting a transport cycle that is electrically neutral (Rudnick et al., 1983; Gu et al., 1994; Rudnick, 1998a) . However, additional ion conducting states have been associated with SERTs (Mager et al., 1994; Lester et al., 1996) as well as homologous NE (Galli et al., 1995 (Galli et al., , 1996 and DA transporters (Sonders et al., 1997) . For SERTs, these conducting states include (1) a constitutive leak pathway and (2) a substrate-activated current. In Xenopus laevis oocytes expressing rat SERT (rSERT), both the SERT leak and substrate-gated currents are potentiated by medium acidification, suggesting that the transporter is also highly permeable to protons (Cao et al., 1997 (Cao et al., , 1998 . Whether these ion-conducting states use a common permeation pathway and whether this pathway is shared with the pathway along which 5HT translocates is currently unknown.
The availability of cDNAs encoding SERTs provides the molecular tools necessary for a structural dissection of the transporter to identify residues or domains critical for substrate recognition and translocation, ion coupling, and antagonist blockade. In the present studies, we identified a residue in TMD I with a binary option (Asp or Gly) among the Na ϩ -and Cl Ϫ -dependent transporters and established that reversal of this residue in either human norepinephrine transporter (NET) (D75G) or rat SERT (D98G), or several other substitutions, caused a disruption of amine transport activity. However, the rSERT mutant D98E retained significant 5HT transport activity, allowing us to explore the consequences of this more conservative substitution on substrate and antagonist recognition, ion dependence, and SERTmediated ion flow. Our findings link determinants of 5HT, ion recognition, and nonstoichiometric ion flow, suggesting that TMD I is one of several domains that may line a common permeation pathway for permeant species transiting the membrane through biogenic amine transporters.
MATERIALS AND METHODS
Site-directed mutagenesis. Point mutations were introduced into the wildtype rSERT and hN ET cDNAs by oligonucleotide-directed mutagenesis as described previously (Kunkel et al., 1987) . A single-stranded uracilcontaining DNA template was generated in Escherichia coli C J236 (dut-, ung-) (Invitrogen) using R408 helper phage. Using oligonucleotides encoding the mutations, the following mutations were introduced: rSERT D98A, D98E, D98G, D98N, D98T, and hN ET D75A, D75E, D75G, and D75N. Identity of the mutant cDNAs was confirmed by dideoxynucleotide sequencing using a Sequenase-II kit (United States Biochemicals) (Sanger et al., 1977) . To verif y the absence of additional mutations in the parental cDNAs, rescue constructs of all mutations were constructed. For the SERT mutant rescues, the XhoI / RsrII fragment containing the various D98 mutations was removed from the mutantcontaining cDNAs, and the corresponding fragment from the wild-type rSERT cDNA was ligated into D98 mutant cDNAs. For the hN ET mutant rescues, the ScaI fragment containing the various D75 mutations was removed from the mutant-containing cDNA, and the corresponding fragment from the wild-type hN ET was ligated into the D75 mutant constructs. The rescue constructs were tested for recovery of transport activity in either [ 3 H]5HT or [ 3 H ]N E uptake experiments. In all cases, the rescue constructs demonstrated wild-type rSERT or hN ET transport activity (data not shown), confirming that the disruption of transport activity observed for the rSERT D98 and hN ET D75 mutants resulted from the single mutation.
Transient e xpression of SERTs in mammalian cells. To directly assess transport activity of rSERT (Blakely et al., 1991a) and the rSERT D98 mutants, as well as hN ET (Pacholczyk et al., 1991) and hN ET mutants, transient expression of the transporters was achieved using the recombinant vaccinia virus T7 expression system in HeLa cells (Fuerst et al., 1986; Blakely et al., 1991b) . The parental cDNAs, rSERT and hN ET, were previously cloned into the plasmids pBluescript II K SϪ and pBluescript II SKϩ, respectively. In each case, sense RNA is transcribed by the plasmid-encoded T7 RNA polymerase promoter. HeLa cells were cultured in DM EM supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and 1% penicillin /streptomycin at 37°C in a humidified 5% CO 2 incubator. C ells plated in 24-well culture plates (100,000 cells per well) were infected with recombinant V V T7-3 vaccinia virus encoding T7 RNA polymerase at 10 plaque-forming units per cell as described (Fuerst et al., 1986; Blakely et al., 1991b) . Virus infection of the cells proceeded for 30 min in serum-free Opti-M EM I containing 55 M 2-mercaptoethanol at 37°C. After virus infection, SERT or N ET cDNA constructs were transfected into virus-infected HeLa cells using liposome-mediated transfection (Lipofectin reagent) at 100 ng DNA per well at a ratio of 1 g of DNA /3 g of Lipofectin (mixed in Opti-M EM I/␤-mercaptoethanol).
For expression in C OS-7 cells, rSERT and rSERT D98E were subcloned into the XhoI/XbaI site of the mammalian expression vector pcDNA3 (Invitrogen). This construct would place SERT expression under control of the cytomegalovirus promoter suitable for expression in C OS-7 cells. Parental C OS-7 cells were cultured in DM EM supplemented with 10% fetal bovine serum, 2 mM glutamine, and 1% penicillin / streptomycin at 37°C in a humidified 5% C O 2 environment. For uptake experiments, 100,000 cells per well were plated in 24-well culture plates (Falcon) and transfected with rSERT or D98E cDNA using 100 ng / well and a 5:1 ratio of Lipofectin reagent / DNA. Medium containing DNA and Lipofectin was removed 16 -18 hr after transfection and replaced with complete DM EM culture medium. C ells were used in uptake assays 48 hr later. For cell-surface biotinylation experiments, cells (200,000 cells per well) in six-well culture plates were transfected with rSERT or D98E cDNA using 2 g DNA / well and a 5:1 ratio of Lipofectin / DNA. Medium containing DNA and Lipofectin was removed 16 -18 hr after transfection and replaced with complete DM EM culture medium. C ells were used in biotinylation experiments (see below) 48 hr later. (Cheng and Prusoff, 1973 125 I]RTI-55 (N EN Life Science Products; ϳ2200 C i /mmol) were performed on wild-type and mutant rSERTs to assess whether mutationinduced alterations in transport correlated with changes in ligand binding. To prepare crude membranes, HeLa cells were transfected with SERT cDNAs as described for transport assays, except that cells were plated on 150 mM culture dishes and used 12-16 hr after transfection to maximize SERT expression. C ells were washed with PBS, incubated in ice-cold hypotonic buffer (Tris-HC l 50 mM, pH 7.4, NaC l 100 mM), detached from the plates using a cell scraper, and pelleted at 1600 ϫ g. The resulting pellet was resuspended in ice-cold Tris/ NaC l buffer and centrif uged for 20 min at 20,000 ϫ g. The resulting pellet was resuspended with a Brinkmann polytron (5 sec, 25,000 rpm) and centrif uged for an additional 20 min at 20,000 ϫ g. The pellet was suspended in Tris/ NaC l buffer and homogenized with the polytron (10 sec, 20,000 rpm). Samples of membrane suspensions were frozen at Ϫ80°C before use. T ypically, assays were performed using 1 g (rSERT) and 10 g (D98E) of membrane protein as determined by the Bradford protein assay (Bio-Rad) using bovine serum albumin as the standard. Saturation binding was determined in duplicate using 0.1-20 nM [ 125 I]RTI-55 with 1 M paroxetine used to define nonspecific binding (K d and B max values: wild-type rSERT 0.37 Ϯ 0.02 nM and 5.6 Ϯ 0.45 ϫ 10 Ϫ12 mol /mg protein; D98E 3.7 Ϯ 0.6 nM and 5.4 Ϯ 0.35 ϫ 10 Ϫ12 mol /mg protein). In competition binding experiments, cells were incubated with increasing concentrations of antagonist before the addition of either 0.1 nM (wildtype rSERT) or 1.0 nM (D98E) [ 125 I]RTI-55. Assay tubes were incubated for 1 hr at 22°C and filtered using a Brandel harvester through Schleicher and Schuell #32 glass fiber filters soaked in 0.5% polyethylenimine. Bound radioactivity was measured by gamma emission spectrometry. K i values were derived by nonlinear least-square fits (Kaleidagraph, Synergy Software) using a four-parameter logistic equation with necessary adjustments of IC 50 values for radioligand concentration to determine apparent K i values (Cheng and Prusoff, 1973) .
Cell-surface biotinylation of SERT and NET proteins. To determine cell-surface expression levels of the wild-type rSERT, rSERT D98E, rSERT D98G, wild-type hN ET, hN ET D75E, and hN ET D75G, cellsurface biotinylation studies using polyclonal antibodies to either rSERT or hN ET for protein detection were undertaken as described previously (Melikian et al., 1996; Qian et al., 1997) . Because of technical limitations regarding the use of the T7-vaccinia virus expression system for quantitative cell-surface biotinylation (Melikian et al., 1996) , all cDNAs were subcloned into the mammalian expression vector pcDNA3 (Invitrogen) for transient expression in C OS-7 cells. Forty-eight hours after transfection, cells were washed with cold PBS/C a-Mg (138 mM NaC l, 2.7 mM KC l, 1.5 mM KH 2 PO 4 , 9.6 mM Na 2 HPO 4 , 1 mM MgC l 2 , 0.1 mM CaCl 2 , pH 7.3) and then treated with freshly prepared Sulfo-N HS-Biotin (sulfosuccinimidobiotin; Pierce) (1.5 mg /ml in PBS/C a-Mg) at 4°C for 30 min. Biotinylating reagents were removed by washing with 100 mM glycine in PBS/C a-Mg, the reaction was f urther quenched by incubation with 100 mM glycine for 20 min, and then cells were washed with PBS/C a-Mg before lysis with RI PA buffer (10 mM Tris-Base, pH 7.4, 150 mM NaC l, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate) supplemented with protease inhibitors (1 g /ml leupeptin, 1 M pepstatin, 1 mg /ml soybean trypsin inhibitors, 1 mM iodoacetamide, and 250 mM PMSF) for 30 min at 4°C with constant shaking. Lysates were centrif uged at 20,000 ϫ g for 30 min at 4°C, and supernatants were incubated with monomeric avidin beads (175 l bead volume/1250 l supernatant) for 1 hr at room temperature. Beads were washed four times with RI PA, and adsorbed proteins were eluted with 50 l of 2ϫ Laemmli loading buffer (62.5 mM Tris-HC l, pH 6.8, 20% glycerol, 2% SDS, 5% ␤-mercaptoethanol, and 5% bromophenol blue) for 30 min at room temperature. A fraction of total cell lysate (20 of 800 l), lysates after incubation with avidin beads (intracellular proteins) (20 of 800 l), the final wash (40 of 800 l), and the entire bead eluate (50 l) were separated by SDS-PAGE (10%), transferred for 16 hr at 150 mA onto poly vinylidene difluoride membrane, blocked with 5% nonfat dry milk in PBS/0.1% T ween-80, and immunoblotted with anti-SERT C T-2 (1:5000) (Qian et al., 1995) or anti-N ET (1:5000) (Melikian et al., 1994) antibodies using 1:5000 goat anti-rabbit HRP-conjugated secondary antibody. Subsequently, blots were stripped (62.5 mM Tris-HC l, pH 6.8, 2% SDS, and 100 mM ␤-mercaptoethanol) for 30 min at 50°C, washed with PBS/ T ween-80 twice for 10 min, reblocked with 5% dry milk for 1 hr, and probed with anti-calnexin antibody (StressGen) (1:3000) followed by goat anti-rabbit HRP-conjugated secondary antibody (1:5000). Immunoreactive bands were visualized by ECL chemiluminescent detection (Amersham) on Hyperfilm ECL (Amersham), and scanned bands were quantitated using ImageQuant (Molecular Dynamics). Multiple exposures were used to insure quantitation within the linear range of the film. Values of SERT or N ET surface proteins were normalized by levels of calnexin immunoreactivity in total cell extracts and biotinylated (cellsurface) fractions compared with the total fractions to control for different expression levels of each clone.
Two-electrode voltage clamp of SERT-e xpressing Xenopus ooc ytes. The plasmids (pBluescript SK II(Ϫ)) containing the cDNAs for either wildtype rSERT (Blakely et al., 1991a) or the D98E mutant were linearized with XbaI, and cRNA was transcribed using the mMessage mMachine T7 In V itro Transcription K it (Ambion). Stage V and V I defolliculated oocytes were subsequently injected with 50 -100 ng of either wild-type rSERT or D98E cRNA and maintained at 18°C in C a 2ϩ -Ringer's solution (96 mM NaC l, 2 mM KC l, 5 mM MgC l 2 , 5 mM H EPES, and 0.6 mM CaCl 2 , pH 7.6) supplemented with 1% penicillin /streptomycin (Life Technologies/ BRL) and 5% horse serum (Life Technologies/ BRL). Isotonic replacement of Na ϩ with NMDG was used in the Ca 2ϩ -Ringer's solution for experiments performed in the absence of Na ϩ . Oocytes were used 6 -8 d after cRNA injection. Resting membrane potentials for oocytes used in recording experiments ranged from Ϫ39 to Ϫ52 mV.
T wo-electrode voltage-clamp was performed on SERT-expressing oocytes using an AxoC lamp 2A (Axon Instruments). Voltage-clamp glass microelectrodes were filled with 3N KC l solutions and pulled to a resistance of 0.5-5 M⍀. The recording solutions used to perf use the oocytes consisted of room temperature C a 2ϩ -Ringer's at pH 4.5, 5.0, 5.5, 6.0, or 7.6 as indicated in the Figure legends. Perf usion was controlled by gravity at a rate of ϳ6 ml /min. Data acquisition and analysis were recorded and stored digitally (MacLab 2e interface) using MacLab v. 3.4 (AD Instruments). I-V relationships were determined using voltageramp protocols: oocyte membrane potential was held at Ϫ40 mV with voltage ramp (Ϫ120 to ϩ60 mV) applied over 10 sec. [ 3 H]5HT uptake in SERT-expressing oocytes was performed in C a 2ϩ -Ringer's containing 20 nM [ 3 H]5HT, 100 M pargyline, and 100 M L-ascorbic acid for 30 min at room temperature. Nonspecific uptake was determined by assaying uninjected or water-injected oocytes in parallel with the wild-type rSERT-and D98E-injected oocytes.
RESULTS

The conserved Asp in TMD I of the monoamine transporters is critical for transport activity and ion dependence
Transporter chimeras and species-scanning mutagenesis studies (Barker and Blakely, 1996) have identified residues within SERT TMDs I (Barker et al., 1998) and XII (Barker et al., 1994; Barker and Blakely, 1996) that participate in competitive antagonist recognition. In evaluation of a TMD I residue (Y95 in hSERT and rSERT) that participates in SERT antagonist recognition (Barker et al., 1998) , we recognized that this residue was one helical turn below a biogenic amine transporter-specific acidic residue (D98 in SERTs) ( Fig. 1 A) that had been implicated in substrate recognition (Kitayama et al., 1992) . All other members of the gene family (e.g., GABA, glycine, proline transporters) possess a Gly (G) in the equivalent position, a binary option that may suggest a constrained role in transport function. Mutation of the TMD I Asp residue in the DA transporter (DAT) leads to a disruption of DA transport and cocaine analog recognition (Kitayama et al., 1992) . On the basis of the proposed role of a conserved Asp residue in TMD III of adrenergic receptors for coordinating the binding of the amine side chain of catecholamines (Strader et al., 1989 (Strader et al., , 1991 and the absolute conservation of this residue in monoamine neurotransmitter transporters, Kitayama et al. (1992) hypothesized that this residue coordinates interactions with the protonated alkylamine of substrates. Lacking from the previous studies, however, is evidence of complementarity between sites mutated in the transporter and functional substitutions on substrates or antagonists that can enhance arguments for direct ligand/transporter interactions.
To test whether the conserved Asp in TMD I ( Fig. 1 A) plays a critical and general role in biogenic amine transporter function, we introduced several mutations at this position in both rSERT (D98) and hNET (D75). Analysis of radiolabeled neurotransmitter uptake after transient expression of SERT D98 or NET D75 mutants revealed that most mutations completely abolished transport activity, including the switch to Gly generated to mimic the natural deviation in other family members ( Fig. 1 B,C) . The more conservative mutation D75E in hNET was also nonfunctional, but strikingly the rSERT D98E mutant retained 35-50% of wildtype rSERT activity. This retention of transport function allowed us to characterize properties of the D98E mutant that were inaccessible in the other substitutions. Thus we found that transient expression of rSERT D98E in both HeLa (data not shown) and COS-7 cells (Fig. 1 D, Table 1 ) reduced 5HT transport capacity (V max ) by ϳ50% with little or no change in the 5HT K m value.
To determine whether the reduced V max values obtained for the D98E mutant in COS-7 cells was caused by reduced translation or surface expression of mutant transporters, immunoprecipitation and cell-surface biotinylation experiments were performed (Melikian et al., 1996; Ramamoorthy et al., 1998) . All hNET and rSERT mutants were found to be synthesized at equivalent levels as assessed by immunoprecipitations of [
35 S]-labeled cell extracts (data not shown). Direct immunoblots of rSERT-transfected and rSERT mutant-transfected COS-7 cells validated no differences in steady-state protein levels (Fig. 2 A) . SERT and immunoreactive proteins in COS-7 cells are revealed as two bands of 95 and 105 kDa for both the wild-type and D98E construct that are absent from vector-transfected cells. The two bands, we suspect, represent migration attributable to heterogeneous glycosylation (Qian et al., 1995) , although we did not explore this in detail. Both isoforms were collected from biotinylated cell fractions that are depleted of the intracellular marker calnexin (Fig. 2 A) and thus appear to be expressed on the cell surface. When normalized to total calnexin content, no change was evident in D98G surface levels, whereas a small but insignificant decrease in surface SERT protein for the D98E mutant was detected. Wild-type levels of synthesis and cell-surface expression were also seen for the hNET D75E (Fig. 2 B) and D75G mutants (data not shown), demonstrating that a disruption of protein stability and/or trafficking cannot account for the loss of transport capacity observed in hNET D75 or rSERT D98 mutants.
Another property of SERTs that might be compromised by D98E and explain a loss of transport capacity is an alteration in Na ϩ or Cl Ϫ recognition that provides for energetic coupling to drive 5HT influx. Complete substitution for Na ϩ using lithium or NMDG or for Cl Ϫ with gluconate and nitrate salts resulted in a full loss of 5HT transport for both SERT-transfected and SERT D98E-transfected cells (data not shown), revealing a retention of ion dependence for amine uptake. However, when we titrated Na ϩ with NMDG or Cl Ϫ with gluconate, we found that SERT D98E exhibited a markedly altered ion dependence (Table 1) . As described previously (Rudnick and Clark, 1993; Gu et al., 1994) , Na ϩ concentration-dependence data for rSERT could be fit to a single hyperbolic f unction, consistent with a 1 Na ϩ /1 5HT coupling stoichiometry. In contrast, Na ϩ dependence for D98E did not saturate in an isotonic substitution range, yielding a K m value we could only estimate as Ն100 mM (vs ϳ20 mM for rSERT). Cl Ϫ dependence for either rSERT or rSERT D98E could be fit to a single hyperbolic f unction as reported previously , supportive of a 1 Cl Ϫ /1 5HT ϩ coupling stoichiometry. However, in rSERT D98E we found an eightfold increase in the Cl Ϫ K m value. These findings indicate that the D98E mutation compromises utilization of external Na ϩ and C l Ϫ for catalyzing inward 5HT transport, effects that may explain the reduction in 5HT transport capacity in the face of little or no reduction in surface expression or alteration in 5HT K m value.
D98E differentially alters antagonist potency
Pharmacological characterization of the rSERT D98E mutant by [ 3 H]5HT transport inhibition experiments revealed selective alterations in SERT antagonist potencies (Table 1) . Thus, paroxetine and mazindol potency were essentially equal at both wildtype rSERT and D98E mutant. Cocaine and imipramine exhibited a three-to fivefold reduction in potency. Of the SSRIs tested, citalopram potency was most severely affected, with a 100-fold loss of potency at the rSERT D98E mutant. We confirmed these effects using [
125 I] RTI-55-labeled competition binding experiments (Boja et al., 1992; Wall et al., 1993) . RTI-55 is a substituted phenyltropane like cocaine, and its K d value for binding to SERT was significantly increased at D98E (0.37 nM vs 3.7 nM) as were the K i values of cocaine (133 Ϯ 35 nM vs 580 Ϯ 160 nM) and imipramine (11.2 Ϯ 2 nM vs 94 Ϯ 34 nM). Interestingly, in these assays 5HT displayed a sixfold loss of affinity as an inhibitor of [
125 I]RTI-55 binding (184 Ϯ 40 nM vs 1160 Ϯ 130 nM), suggesting that 5HT recognition is subject to conformational accommodations of 5HT or SERT or both under the conditions used for transport. Alternatively, kinetic terms besides 5HT binding that can influence the K m value (Rudnick, 1998b ) may have been perturbed by D98E, offsetting affinity losses. [
125 I]RTI-55 B max values were equivalent for rSERT and rSERT D98E, consistent with no major loss in SERT protein expression induced by the mutation.
Selective effects of D98E on substrate recognition
The previous proposal (Kitayama et al., 1992 ) that amine substrate recognition involves ion pairing between the Asp side chain carboxylic acid and the positively charged amine group on amine substrates, as in G-protein-coupled amine receptors (Strader et al., 1989 (Strader et al., , 1991 , suggests that mutations at D98 of rSERT might be offset by specific structural modifications of 5HT or analogs, in particular modifications of the alkylamine chain extending from the indole ring. We identified two 5HT derivatives, dimethyltryptamine (DMT) and gramine (Fig. 3A) , that differ only in the length of their amine-containing side chain. If the ethylamine of DMT interacts with the carboxylic acid at D98 (Fig. 3A) , shortening the alkylamine chain by one carbon to yield gramine should disrupt this interaction and lead to lower potency inhibition of 5HT uptake (Fig. 3B) ; however, gramine should reestablish this ion pair if the carboxylic acid at D98 is lengthened by one carbon as in the D98E mutation (Fig. 3C) . When the potencies of DMT and gramine for inhibition of 5HT uptake were compared at the wild-type rSERT and the D98E mutant, we found that DMT interacts with both the wild-type and mutant transporter equivalently (Fig. 3D , Table 2 ). The shorter-chain gramine is more than one order of magnitude weaker than DMT as a 5HT uptake inhibitor at wild-type rSERT (Fig. 3D, Table 2 ). Remarkably, gramine became a more potent inhibitor of 5HT uptake when tested on SERT D98E, a potency indistinguishable from DMT or 5HT at wild-type rSERT (Fig. 3D, Table 2 ). The preference of the D98E mutant for the shorter methylamine derivative was selective in that other substitutions on the tryptamine structure (e.g., 5Ј-OH, indole N, alkylamine methylation) were insensitive to the increased chain length associated with the D98E mutation (Table 2) . Furthermore, we sought other structures that might generalize an interaction of the alkylamine side chain with the carboxylic acid at rSERT D98. DA and its methylamine derivative dihydroxybenzylamine (DHBA) are weak inhibitors of 5HT uptake relative to the tryptamines; however, they present a similar opportunity to adjust the alkylamine side chain length by one carbon and test for a gain of function to the D98E mutation. We found that DHBA is more than one order of magnitude less potent than DA at inhibiting 5HT uptake by wild-type rSERT, whereas the two compounds are comparable in potency at the D98E mutant because of a reduced potency of DA and a gain of function for DHBA (Table 2) .
rSERT D98E disrupts substrate-gated ion flow
To gain further insights into the functional impact of the D98E mutation and its interaction with tryptamine derivatives, we examined substrate-induced currents in voltage-clamped Xenopus oocytes. Electrophysiological measurements in transporterexpressing oocytes have demonstrated that substrates, but not antagonists, activate transporter-associated currents (Mager et al., 1994; Sonders et al., 1997 (Mager et al., 1994) , saturating concentrations of 5HT induced an inward current at pH 7.6 in oocytes expressing the wild-type rSERT voltage clamped at Ϫ80 mV (Fig. 4 A) . These currents are blocked by imipramine and are absent from uninjected oocytes. Surprisingly, the D98E mutant demonstrated little (Ͻ2 nA) to no measurable 5HT-induced current at pH 7.6 (Fig. 4 B) . This was remarkable because [ 3 H]5HT uptake activity for the D98E mutant assayed in the same batches of oocytes used for voltage-clamp experiments was reduced only ϳ40% as compared with wild-type rSERT (Fig.  4C ), similar to findings in C OS-7 cells. L owering buffer pH from 7.6 enhanced both a leak current as well as 5HT-induced currents (Cao et al., 1997) . We retested rSERT and D98E at pH 5.0 and found that both transporters exhibited increased leak currents (see below), and we were able to significantly increase 5HT-gated currents in the wild-type transporter (Fig. 4 A) . Moreover, acidic medium pH allowed us to uncover substrate-gated ion flow in the SERT D98E (Fig. 4 B) . At pH 5.0, we confirmed that 5HT and DMT, as well as gramine, induce currents in the D98E mutant, indicating that all three compounds behave as substrates for the transporter. Consistent with this notion, imipramine (Fig. 4 A,B ) blocked all substrate-induced currents in D98E-injected oocytes tested at pH 5.0 and revealed an outward current presumably attributable to block of a substrate-independent inward leak (Mager et al., 1994) . Thus both wild-type rSERT and rSERT D98E are expressed in the oocyte, but acidic pH is required to reveal substrate-induced currents for D98E. This does not occur because acidic pH allows substrates to permeate more readily because the shift to pH 5.0 actually diminishes 5HT transport activity more for D98E than for rSERT (Fig. 4C) , suggesting that D98E perturbs the transporter's charge movement/substrate flux ratio. The presence of DMT-and gramine-induced currents in D98E-expressing oocytes (measured at pH 5.0) allowed us to seek evidence for a shift in gramine K m value as a transported substrate as predicted by the 5HT uptake inhibition studies reported in COS-7 cells. Thus we measured inward currents at pH 5.0 induced by increasing concentrations of gramine in oocytes expressing either wild-type rSERT or the D98E mutant (Fig. 5A) . In both cases, gramine-induced currents were saturable and fit readily with single hyperbolic functions. Analyses of these fits revealed a sevenfold increase in the potency (decreased K m value) for gramine-activated currents at the D98E mutant (0.3 Ϯ 0.04 M) as compared with wild-type rSERT (2.2 Ϯ 0.4 M). Thus, gramine is more potent at the D98E mutant in both 5HT transport inhibition assays and in activation of substrate-dependent ion flow. At saturating concentrations at pH 5, gramine and 5HT gated equivalent levels of whole-cell current (I max ) for the D98E mutant, whereas gramine was less efficacious than 5HT at wildtype rSERT (Fig. 5B) . This indicates that gramine is not only a more potent substrate for the D98E mutant, but also D98E shifts Figure 2 . SERT and NET TMD I Asp mutants do not alter transporter cell-surface expression. C OS-7 cells were transfected with rSERT, D98E, D98G, or pcDNA3 vector (control), and cell-surface biotinylation experiments were performed as described in Materials and Methods. A, Immunoblots identif ying rSERT and rSERT mutants using SERT-specific antibody C T-2B (Qian et al., 1995) . B, Immunoblots identif ying hN ET and hNET D75E mutant using NET-specific antibody (Melikian et al., 1994) . After blots were probed with the anti-SERT or anti-N ET antibodies, membranes were stripped and reprobed with anti-calnexin antibody (StressGen). Because calnexin is a endoplasmic reticulum transmembrane protein, it is a marker for intracellular proteins. Low levels of calnexin bands (Ͻ0.5% of total) were detectable in the cell-surface lanes, suggesting only minor contamination of biotinylated (cell surface) fractions with intracellular proteins. Density of bands was determined using scanning densitometry (ImageQuant, Molecular Dynamics) with SERT total fractions normalized to total calnexin immunoreactivity. Data presented are representative of three separate experiments.
the relative efficiency of gramine to gate substrate-activated currents to a level comparable to that observed for 5HT.
A change in ion selectivity induced by rSERT D98E
The lack of detectable substrate-gated currents for the rSERT D98E mutant at pH 7.6 (Fig. 4 B) despite significant 5HT uptake in unclamped oocytes and changes in charge/substrate flux ratios suggested a mutation-induced disruption in a specific aspect of 5HT-gated ionic permeation. Na ϩ is involved in gating inward current flow (Mager et al., 1994) and has been proposed as the major charge-carrying species in the leak pathway at neutral pH (Lin et al., 1996) . Protons appear to readily permeate biogenic amine transporters in the absence of amine substrates (Sonders et al., 1997) and may also contribute to the substrate-gated current at acidic extracellular pH (C ao et al., 1997). We thus asked whether D98E alters Na ϩ or pH dependence or both for leak or substrate-activated currents. As described previously (Mager et al., 1994; Cao et al., 1997; Galli et al., 1997) , Na ϩ dependence of 5HT-activated inward currents was evident when NMDG was substituted for Na ϩ on wild-type rSERT at pH 7. 6. At pH 5.0, where 5HT-activated currents can be detected in rSERT D98E, we found a similar loss of currents on Na ϩ substitution (Fig.  6 A,B) . Thus, as with 5HT transport activity measured in COS-7 cells, a dependence on extracellular Na ϩ for gating nonstoichiometric ion flow is retained in the D98E mutant. 5HT application to rSERT-injected or rSERT D98E-injected oocytes in NMDG buffer revealed outward currents (Fig. 6 A,B) , consistent with Na ϩ -independent 5HT binding to SERTs (Mager et al., 1994; Cao et al., 1997; Galli et al., 1997) and H ϩ permeation of a leak pathway that 5HT can block (Cao et al., 1997 ) and that appears to be intact in the D98E mutant.
If acidic medium is required to detect substrate-activated currents for the D98E mutant in Na ϩ buffer, decreased pH may titrate residues that restore Na ϩ permeation through substrateactivated channels, or protons may simply be traversing this pathway. To explore these possibilities, leak and 5HT-gated currents carried by rSERT (Fig. 7A ) and rSERT D98E (Fig. 7B) were studied in Xenopus oocytes as a function of extracellular medium pH. I-V curves were determined by ramp protocols during sequential perfusion with buffer (Ctrl ), substrate (5HT, 5 M), or antagonist [citalopram (Cit), 30 M]. Initial experiments were conducted at pH 5.0 where 5HT can be shown to gate both wild-type rSERT and rSERT D98E currents (Fig. 4 A,B) . The application of citalopram to injected oocytes in the absence of 5HT (but not uninjected oocytes; data not shown) resulted in positive (outward) currents below Ϫ30 mV. The shapes of the subtracted I-V plots were similar comparing mutant and wildtype SERTs (data not shown). The reversal potential for these currents (I C it -I C trl ) was unmodified by the D98E mutation (wildtype rSERT Ϫ12.2 Ϯ 5.8 mV vs D98E Ϫ6.0 Ϯ 3.5 mV). Similarly, Figure 3 . Structure-activity studies with tryptamine derivatives and the rSERT D98E mutant implicate a direct interaction between neurotransmitter and D98. A, Proposed model for interactions between carboxylic acid of SERT D98 and tryptamine alkylamine group. B, Disruption of carboxylic acid-amine interaction by shortening DMT to the methylamine structure gramine. C, Reestablishing carboxylic acid-amine interactions by lengthening carboxylic acid alkyl chain by one methyl group (D98E) combined with shorter methylamine substrate gramine. D, Evaluation of DMT and gramine potency for inhibition of [ 3 H]5HT uptake at wild-type rSERT and D98E mutant. [ 3 H]5HT uptake assays were performed with transiently transfected C OS-7 cells as described in Materials and Methods, with increasing concentrations of DMT or gramine added simultaneously with the addition of 10 nM [
3 H]5HT. Nonspecific uptake was determined in C OS-7 cells transfected with the parent vector pcDNA3 and subtracted from total values. Data were plotted as percentage of specific 5HT uptake. All data plotted represent means Ϯ SEM of triplicate determinations and are representative of three separate experiments. Apparent K i values are presented in Table 2 . . rSERT D98E mutant does not demonstrate substrate-induced current at pH 7.6. Xenopus oocytes were injected with either wild-type rSERT ( A) or D98E mutant ( B) cRNA, and two-electrode voltage-clamp experiments were performed as described in Materials and Methods. Oocytes were held at Ϫ80 mV and perfused with various tryptamines as indicated. For wild-type rSERT, the 5HT-activated current observed at pH 7.6 was augmented at pH 5.0. Also, the shift to pH 5.0 induced an inward current in the absence of 5HT, consistent with previously published results (C ao et al., 1997) . DMT and gramine experiments were performed at pH 5.0 to increase substrate-induced currents. The transporter antagonist imipramine was capable of inhibiting both 5HT-(data not shown) and gramine-induced currents. For the D98E mutant ( B), 5HT-activated current was not detectable above background at pH 7.6. Substrate-induced currents were observed at pH 5.0, although the magnitude of the inward current was greatly reduced (note change in scale between A and B). No substrate-induced currents at either pH 7.6 or 5.0 were observed for water-injected or uninjected oocytes (data not shown). The results shown are from single oocytes expressing either wild-type rSERT or the D98E mutant and are representative of data from six separate oocytes. C, Comparison of [ 3 H]5HT uptake in Xenopus oocytes injected with wild-type rSERT or D98E cRNA. Oocytes injected with wild-type rSERT cRNA, D98E mutant cRNA, or water (control) were incubated in the presence of 10 nM [ 3 H]5HT for 30 min in room temperature Ca 2ϩ -Ringer's, pH 7.6 or 5.0, as described in Materials and Methods. Data represent total [ 3 H]5HT uptake (cpm) (n ϭ 9).
the effect of pH change on the reversal potential of the leak current was similar in both wild-type rSERT and the D98E mutant, with slopes of 42 mV/pH unit and 46 mV/pH unit, respectively (Fig. 7C) , suggesting that protons carry a significant fraction of current in the leak pathway at pH 5.0 and confirming that H ϩ permeation in the absence of substrate (leak) is unperturbed by the D98E mutation.
The addition of 5HT to transporter-injected oocytes elicited inward currents at all potentials (I 5HT ), increasing in magnitude relative to I C trl at negative voltages for both wild-type and rSERT D98E. When normalized for maximum current, the shape of the I 5HT -I C trl plot was similar, indicating a comparable overall voltage dependence to the substrate-activated current (data not shown). However, the I 5HT profile for D98E was noticeably shifted to the right relative to I 5HT for wild-type SERT (X intercept at Ϫ18 mV for SERT vs 0 mV for D98E), suggesting a change in the permeant species carrying the substrate-induced current. Because I 5HT never becomes outward relative to I C trl (Mager et al., 1994; Galli et al., 1995; Sonders et al., 1997) , this may reflect the ability of the substrate to induce an inward current at negative potentials and block outward leak currents at positive potentials. Regardless, a true reversal potential for this current (plotted as I 5HT -I C trl ) cannot be calculated. However, because antagonist blocks both leak and substrate-activated currents, I 5HT does intersect with I C it , defining the total composite SERT current arising from substrate occupancy. When I 5HT -I C it was plotted as a function of pH, the reversal potential for wild-type rSERT demonstrated a 28 mV shift per pH unit change consistent with a partial contribution of H ϩ to 5HT-gated ion flow (Fig. 7D ). In contrast, the D98E mutant exhibited a 53 mV shift in reversal potential per pH unit change, a value approaching the predicted value for a pure H ϩ -selective current (58 mV). These data suggest that acidic medium does not restore conductance of the same permeant species to D98E that define the substrateactivated current in rSERT. Rather, the acidic extracellular medium appears to provide a source of permeant ions for a channel that, like the leak pathway, is highly permeant to H ϩ .
DISCUSSION
SERTs, like other members of the Na ϩ -dependent transporter family, are multi-functional proteins. First identified as mediators of 5HT uptake across brain and platelet membranes, SERTs are now recognized as major targets for antidepressants and psychostimulants (Barker and Blakely, 1995) . In addition to these transport-associated processes, SERTs have multiple ion channellike conducting states (Mager et al., 1994; Lester et al., 1996; Lin et al., 1996; Galli et al., 1997) that are sensitive to competitive transport antagonists. The structural requirements for substrate recognition, antagonist selectivity and 5HT-gated ion flow are as yet largely undefined and may involve nonoverlapping determinants. Alternatively, neurotransmitter and ion permeation may share a common permeation pathway. Our data indicate that D98 in TMD I of SERT influences antagonist recognition and acts as a selectivity determinant for substrate recognition and substrategated ion flow, linking TMD I to cocaine and antidepressantsensitive permeation pathways for both neurotransmitter and nonstoichiometric ion flow.
Although most mutations at the Asp residue in TMD I for NET and SERT were nonfunctional, rSERT D98E retained significant transport activity, allowing investigation into the role of Asp98 in transporter function. The unaffected potency of several transporter antagonists as well as a wild-type K m value for 5HT in the D98E mutant supports a lack of mutation-induced perturbations in SERT structure. Our major kinetic finding was reduced 5HT transport capacity (V max ) that did not appear to arise from reduced translation or surface expression, suggesting inefficient substrate translocation. 5HT can bind to SERTs in the absence of Na ϩ and Cl Ϫ (Humphreys et al., 1994) , but the amine does not translocate. D98E ion dependence demonstrated a shift of both Na ϩ and Cl Ϫ dependence to higher K m values. The Na ϩ K m value for D98E was out of the isotonic range, making quantitative modeling of this perturbation on 5HT uptake difficult. However, using a Na ϩ K m value of 100 mM and the derived Cl ably close to the measured reduction in C OS-7 cells. Our findings suggest that major determinants for both Na ϩ and C l Ϫ coupling reside within TMD I, although we cannot rule out a mutational effect on critical contact sites that lie outside this region. In keeping with a role for TMD I in ion dependence, Mager and coworkers (1996) found disrupted Na ϩ transient currents from mutation of a conserved TMD I tryptophan in GAT1 (W103 in rSERT), and Chen et al. (1997a) noted a cation dependence to methanethiosulfonate inactivation of rSERT C109, a residue in the extracellular loop between TMDs I and II.
Models of ␤-adrenergic receptor interactions with catecholamines propose a direct coordination of the positively charged alkylamine of ligands with the negatively charged carboxylic acid of a conserved TMD III Asp (Strader et al., 1991) . To support this model, Strader and coworkers (1991) found that catecholamine derivatives could compensate for mutations in the ␤-adrenergic receptor. Thus, mutation of the Asp (D113) in TMD III to Ser (D113S), thereby replacing the carboxylic acid with a hydroxyl group, results in mutant receptors that can be activated by ligands possessing hydrogen bond-accepting groups A, I-V plots for currents for wild-type rSERT. B, I-V plots for currents for D98E mutant. All experiments were performed at pH 5.0. Data shown are representative of recordings from single oocytes expressing either wild-type rSERT or D98E mutant (n ϭ 9 -12). C, Effect of pH on reversal potential of substrateindependent transporter-associated leak current (I C trl -I Cit ) for rSERT (Ⅺ, solid line) and D98E mutant (f, dashed line). Data plotted are means Ϯ SEM (n ϭ 7-9) fit to least-square linear regression with slopes of Ϫ42 mV/pH U (rSERT; r ϭ 0.99) and Ϫ46 mV/pH U (D98E; r ϭ 0.99). D, Effect of pH on reversal potential of 5HT-activated transporter-specific current (I 5HT -I Cit ) for rSERT (Ⅺ, solid line) and D98E mutant (f, dashed line). Data plotted are means Ϯ SEM (n ϭ 7-12) fit to least-square linear regression with slopes of Ϫ28 mV/pH U (rSERT; r ϭ 0.99) and Ϫ53 mV/pH U (D98E; r ϭ 0.98).
in place of the alkylamine side chain. Similar findings of complementarity between mutant transporters and "mutant" ligands would increase the implications that direct contacts between ligands and transporters were being evaluated through sitedirected mutagenesis. In the present study, we found that the D98E mutant compensates for disruptions in potency induced by alterations in substrate structure. Thus, gramine, bearing a methylamine side chain, was significantly more potent both as an inhibitor of 5HT uptake and at activating substrate-induced currents at the mutant D98E as compared with wild-type rSERT. Although the effect was not as dramatic as that seen with gramine, the shorter-chained analog of dopamine, DHBA, showed a similar preference for D98E, suggesting that catecholamines may be coordinated similarly to indoleamines, at least by SERTs. Interestingly, Buck and Amara (1994) also have implicated TMD I in substrate recognition for DATs through chimera studies. Antagonist ([ 125 I]RTI-55) binding studies revealed a loss of affinity for 5HT at D98E, whereas uptake studies revealed no change in the 5HT K m value. The determination of the transport K m includes steps distal to binding, including translocation and release of substrates, and these additional steps may offset mutationinduced effects on 5HT binding. Additionally, the conditions of transport versus binding assays (e.g., 37°vs 4°C) may allow movements of either the acidic side chain on the transporter or the alkylamine chain of the substrate to accommodate 5HT. Gramine and DHBA, however, may already be in an extended conformation and require the lengthening of the acidic side chain at D98 to recover the potency seen for the ethylamines DMT and 5HT. Because the D98E mutant could promote favorable interactions between gramine with yet another residue, studies evaluating charge -charge interactions in support of this interaction are warranted.
Because D98 influences 5HT transport, we also determined whether this residue represents a critical contact site for transporter antagonists. Evidence such as protection against alkylating agents argues that competitive antagonists such as imipramine and cocaine possess mutually exclusive, overlapping binding sites with 5HT on SERT (Graham et al., 1989) . However, comparisons of radioligand dissociation rates from native SERTs suggest heterogeneity in the binding of SERT antagonists and propose distinct ligand-specific contact sites (Plenge et al., 1987 (Plenge et al., , 1991 . For the D98E mutant, we observed a loss of affinity for cocaine as well as for the cocaine analog RTI-55, the tricyclic imipramine, and the SSRI citalopram. These effects, however, were not shared by all antagonists (e.g., mazindol, paroxetine), consistent with the existence of unique determinants of antagonist recognition. We recently linked Y95 in rSERT, located one helical turn away from D98 in TMD I, with species-specific recognition of some but not all SERT antagonists (Barker et al., 1998) . In the context of our present studies, these findings support a model by which competitive antagonists can physically obstruct substrate binding sites in addition to conformational alterations arising from ligand binding (Ferrer and Javitch, 1998) . Recently, Chen and coworkers (1997b) , using SCAM techniques, identified both I172 and Y176 of TMD III as potential shared sites for the recognition of both 5HT and cocaine, supporting a model whereby TMDs III and I lie close together in the folded configuration of the membraneembedded transporter.
Not only does D98 appear to dictate ligand recognition, but the D98E mutation also compromises the SERT permeation pathway for nonstoichiometric ion flow (Mager et al., 1994; Lin et al., 1996) . No detectable 5HT-induced current was observed for the D98E mutant at pH 7.6. However, the D98E mutant was clearly expressed because (1) transport activity was present, (2) leak currents were intact, and (3) a shift of external pH to pH 5.0 revealed substrate-gated currents. The loss of detectable 5HT-activated current in the D98E mutant expressing oocytes at pH 7.6 could be attributed to either a mutation-induced disruption of gating mechanisms or an alteration in permeant species or both. Because 5HT and other substrates can gate ion flow at pH 5.0 and this activity still requires extracellular Na ϩ , gating of ion flow per se appears to be intact. Single-channel analysis of SERTconducting states has suggested that Na ϩ is a major currentcarrying species for both 5HT-activated and the substrateindependent leak currents (Lin et al., 1996) , although recent studies suggest that H ϩ may have significant permeability through these pathways (Cao et al., 1997; Sonders et al., 1997) . Although the Na ϩ and Cl Ϫ K m values were elevated and can account for a loss of ion-coupled uptake capacity, this reduction in transport would not account for the D98E-induced disruption on 5HT-gated currents at neutral pH because 5HT carries a very small fraction of the total current (Mager et al., 1994; Galli et al., 1997) . Because 5HT is essentially fully protonated at neutral pH, the shift to acidic pH, as argued previously by Cao and coworkers (1997) , must reveal currents not by titrating 5HT but by either (1) titrating a functional group on SERT to permit cation flow disturbed by D98E or (2) increasing the driving force for H ϩ flow across a permeation pathway unaffected by the D98E mutation. Analysis of the pH sensitivity of the reversal potential for the leak pathways of rSERT and D98E confirms that substrateindependent ion flow at acidic pH is essentially intact in D98E. However, although the 5HT-gated current of wild-type rSERT contains other charge carriers besides H ϩ (and probably Na ϩ ), the D98E 5HT-gated current is essentially proton selective. This suggests that the mutation has impacted 5HT-gated ionic selectivity rather than gating per se such that Na ϩ is no longer the major current-carrying species. We attempted to confirm a loss of Na ϩ influx by D98E via [ 22 Na] cotransport studies but found the expression levels of SERTs inadequate to achieve this measurement.
Because the D98E mutant affects the ion coupling of 5HT transport and eliminates a component of the substrate-activated conducting current, both of which involve Na ϩ , ion selectivity in SERT channels may be determined by domains and residues that also participate in coupling 5HT permeation to ion gradients. The simplest model would involve substrate and ion flow, including H ϩ , as routed through a common pathway whereby the D98E mutant retains the ability to pass 5HT and H ϩ but no other ions. As discussed by Cao and coworkers (1997) , the movement of protons through SERTs may involve conduction in a "waterwire" mechanism that Na ϩ and other cations have no access to, whereas Na ϩ conduction may require distinct structural elements that impact selectivity and conduction. Recent studies of Drosophila SERT currents (C. Petersen and L. DeFelice, unpublished observations) reveal anomalous mole fraction effects between Na ϩ and Li ϩ in the leak pathway that are abolished by 5HT, suggesting that the substrate itself may modify cation interactions in a common permeation pathway. Interestingly, GAT1 GABA transporters lack transmitter-gated nonstoichiometric ion flow , and the Gly at the position homologous to D98 in GAT1 may contribute to this biophysical distinction with biogenic amine transporters. We cannot rule out that two pathways for nonstoichiometric ion flow could be gated by 5HT, one involved with proton permeation and a second, affected by the mutation, carrying other ions (and perhaps also 5HT) that comprise the bulk of the nonstoichiometric ion flow at neutral pH. Besides a lack of positive data to support the latter model, 5HT appears to block rather than gate the leak pathway (when tested in the absence of Na ϩ ). In addition, direct single-channel recordings of substrate-independent and substrate-activated channels by Lin and coworkers (1996) indicate a similar conductance for the leak and 5HT-gated permeation pathways. Whichever model is correct, D98, and by extension TMD I, clearly constrains multiple facets of SERT f unction including 5HT, Na ϩ , Cl Ϫ , and antagonist recognition as well as ion permeation, effects that must be accommodated by models linking transporter structure to function. Given the conservation of the TMD I Asp in biogenic amine transporters, we suspect that our findings generalize to NETs and DATs.
